TY  - JOUR 
AU  - Cannata-Andía, Jorge B
AU  - Díaz-Sottolano, Augusto
AU  - Fernández, Pehuén
AU  - Palomo-Antequera, Carmen
AU  - Herrero-Puente, Pablo
AU  - Mouzo, Ricardo
AU  - Carrillo-López, Natalia
AU  - Panizo, Sara
AU  - Ibañez, Guillermo H
AU  - Cusumano, Carlos A
AU  - Ballarino, Carolina
AU  - Sánchez-Polo, Vicente
AU  - Pefaur-Penna, Jacqueline
AU  - Maderuelo-Riesco, Irene
AU  - Calviño Varela, Jesús
AU  - Gómez, Mónica D
AU  - Gómez-Alonso, Carlos
AU  - Cunningham, John
AU  - Naves-Díaz, Manuel
AU  - Douthat, Walter
AU  - Fernández Martín, José L
PY  - 2022
UR  - http://hdl.handle.net/20.500.11940/22160
AB  - [EN] BACKGROUND: Vitamin D status has been implicated in COVID-19 disease. The objective of the COVID-VIT-D trial was to investigate if an oral bolus of cholecalciferol (100,000 IU) administered at hospital admission influences the outcomes of...
LA  - eng
TI  - A single-oral bolus of 100,000 IU of cholecalciferol at hospital admission did not improve outcomes in the COVID-19 disease: the COVID-VIT-D-a randomised multicentre international clinical trial
T2  - BMC Med
M2  - 83
KW  - HULA
VL  - 20
ER  -